. 2014 Jun 11;13:96. doi: 10.1186/1476-511X-13-96

Table 2.

Fatty acid composition of tumour phosphatidylcholine

Tumour PC fatty acids	Diet
Tumour PC fatty acids	0%	3%	9%
LA (18:2n-6)	10.1 ± 1.2^a	13.9 ± 0.4^b	5.1 ± 0.4^c
AA (20:4n-6)	16.5 ± 1.3^a	10.9 ± 0.6^b	6.2 ± 0.3^c
DPA (22:5n-6)	0.9 ± 0.2^a	0.03 ± 0.02^b	0.1 ± 0.1^b
ALA (18:3n-3)	0.1 ± 0.1^a	0^a	0.01 ± 0.01^a
EPA (20:5n-3)	0.1 ± 0.1^a	0.8 ± 0.1^b	3.1 ± 0.2^c
DPA (22:5n-3)	0.2 ± 0.04^a	0.8 ± 0.1^b	1.3 ± 0.6^ab
DHA (22:6n-3)	1.0 ± 0.2^a	1.5 ± 0.3^a	2.7 ± 0.2^b
Total n-6	33.0 ± 2.3^a	28.4 ± 0.6^a	12.5 ± 0.9^b
Total n-3	1.3 ± 0.3^a	3.0 ± 0.3^b	7.2 ± 0.4^c
n-6/n-3 ratio	24.6 ± 6.8^a	9.5 ± 1.1^b	1.7 ± 0.1^c
Total SFA	39.3 ± 1.3^a	41.5 ± 0.4^a	42.1 ± 0.9^a
Total MUFA	26.4 ± 2.2^a	26.2 ± 0.7^a	38.1 ± 1.0^b
Total PUFA	34.3 ± 3.3^a	31.4 ± 0.7^a	19.7 ± 0.6^b
P/S Ratio	0.9 ± 0.2^a	0.8 ± 0.03^a	0.5 ± 0.03^b

n = 4 for the 9% n-3 PUFA diet, n = 5 for both the 0% n-3 and 3% n-3 PUFA diets. Values in the same row not sharing the same superscript are significantly different from one another as determined by a one-way ANOVA (p < 0.05).